Market Overview
The U.S. exoskeleton market covers both rigid frame systems and soft wearable suits deployed in hospitals, factories, construction sites, and defense operations. Medical exoskeletons dominate current revenue, assisting patients with spinal cord injuries, stroke recovery, and mobility impairments, while industrial exoskeletons are rapidly gaining traction in automotive, aerospace, and warehouse settings to reduce musculoskeletal strain.
- •Medical rehabilitation exoskeletons account for the largest share, driven by FDA clearances and clinical adoption
- •Industrial and logistics exoskeletons are the fastest-growing segment as employers prioritize worker safety and ergonomics
- •Soft exosuits and rigid exoskeletons represent two distinct hardware approaches with overlapping use cases
Growth Drivers
An aging U.S. population and rising prevalence of mobility-limiting conditions are expanding the patient pool for medical exoskeletons, while favorable clinical outcomes and expanding insurance reimbursement are accelerating adoption. In the industrial sector, rising healthcare costs associated with workplace injuries and labor shortages are motivating manufacturers and warehouse operators to invest in exoskeleton-assisted workstations.
- •Aging demographics and increasing stroke and spinal cord injury rates drive medical device demand
- •Occupational Safety and Health Administration data and rising workers' compensation costs push industrial adoption
- •DARPA, the Department of Defense, and military programs have funded exoskeleton R&D for load-carrying and endurance applications
- •Advances in lightweight materials, battery density, and AI-assisted motion control are improving usability and reducing costs
Segmentation and Regional Analysis
The U.S. market is the largest national exoskeleton market globally, buoyed by concentrated healthcare infrastructure, advanced manufacturing bases, and substantial government R&D budgets. Key regional hubs include California, Massachusetts, and Michigan, where leading developers cluster near medical device and automotive manufacturing ecosystems.
- •By application: medical rehabilitation, industrial/manufacturing, defense/military, and consumer/fitness
- •By type: powered full-body exoskeletons, partial limb-support systems, and soft textile-based exosuits
- •The U.S. leads globally in market share, followed by Europe and the Asia-Pacific region
Trends and Outlook
What are the recent trends and outlook?
Over the coming years, the market is expected to consolidate around lighter, less-expensive designs as component costs decline and manufacturing scales. Regulatory pathways are maturing as the FDA and OSHA develop clearer guidance for exoskeleton classification and workplace deployment standards. Meanwhile, entry-level industrial exoskeletons and consumer-oriented fitness exosuits are broadening the addressable market beyond traditional hospital and defense buyers.
- •Soft exosuits leveraging textile-based actuation are expected to gain share over rigid-frame alternatives for industrial use
- •AI and sensor fusion for adaptive, personalized assistance is becoming a key product differentiator
- •Expansion into construction, agriculture, and shipping/logistics verticals is widening the industrial addressable market
- •Mergers, acquisitions, and partnerships between robotics startups and established industrial or healthcare firms are likely to increase
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.